Upstream & Downstream Processing
Forge Bio launches pDNA production to support gene therapy clients
Facilities & CapacityForge Bio launches pDNA production to support gene therapy clientsForge Bio launches pDNA production to support gene therapy clients
Forge Biologics has launched pDNA manufacturing services to support its AAV clients after closing a $90 million Series C funding round.
Sponsored Content